The D.C. Circuit Court recently ruled against a request from former President Donald Trump to stay a lower court's order regarding the treatment of federal inmates with gender dysphoria. This decision affects how the Bureau of Prisons (BOP) manages gender-affirming care for inmates, impacting the lives of many individuals within the federal prison system.

The case, Alishea Kingdom v. Donald Trump, was filed on September 18, 2026, under docket number 26-5236. The ruling comes amidst ongoing debates about the rights of transgender individuals in correctional facilities and the responsibilities of the federal government in providing necessary medical care.

The parties involved in this case include Alishea Sophia Kingdom, a federal inmate, and Donald Trump, who was serving as President of the United States at the time of the filing. The dispute centers around the BOP's implementation of Program Statement 5260.01, which outlines the management of inmates with gender dysphoria. This program has drawn criticism for its restrictions on medical treatments that some argue are essential for the well-being of transgender inmates.

The case reached the D.C. Circuit after the district court issued a preliminary injunction against the BOP's new policies. The injunction was intended to prevent the implementation of the program until further review could take place. The BOP's new policies included the cessation of sex reassignment surgeries, hormone therapy, and social accommodations like makeup and wigs for inmates undergoing gender transition.

On September 18, 2026, the D.C. Circuit Court issued its ruling. The court dismissed Trump's motion for a stay in case number 26-5236 as moot, meaning it no longer needed to be considered. The court also denied the motion for a stay in case number 26-5310, stating that the appellants did not meet the stringent requirements necessary for such a stay. The judges involved in the ruling were Wilkins, Walker, and Garcia.

The court ruled, "Appellants have not shown a strong likelihood of success on the question of whether Program Statement 5260.01 is arbitrary and capricious..." This statement highlights the court's view that the BOP did not adequately consider its past experiences with providing gender-affirming care.

The court further noted that the appellants had not made a strong case that the district court's order violated the Prison Litigation Reform Act (PLRA) or that it improperly granted class-wide relief. The ruling emphasized that the arguments presented by the appellants were likely forfeited because they were not raised in the district court initially.

This decision is significant as it reinforces the district court's authority to issue injunctions against government policies that may infringe on the rights of inmates. It also underscores the importance of considering the well-being of transgender individuals in the prison system. The ruling may set a precedent for future cases involving the treatment of inmates with gender dysphoria and the responsibilities of correctional institutions in providing necessary medical care.

The impact of this ruling is substantial for federal inmates who identify as transgender. It affirms the lower court's decision to block the BOP's restrictive policies, ensuring that these inmates have access to gender-affirming care. This case may influence how other courts handle similar issues in the future, potentially leading to broader protections for transgender individuals in correctional facilities.

Looking ahead, it is unclear whether the ruling can be appealed further. The dissenting opinion from Judge Walker indicated that the government may have grounds for appeal based on procedural issues related to the issuance of preliminary injunctions. However, details on any potential appeals or related cases were not available in the court filing.